These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6324042)

  • 1. Oxytocin release is inhibited by opiates from the neural lobe, not those from the intermediate lobe.
    Bicknell RJ; Ingram CD; Leng G
    Neurosci Lett; 1983 Dec; 43(2-3):227-30. PubMed ID: 6324042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous opioid inhibition of the release of oxytocin from the isolated rat neurohypophysis during high-frequency stimulation of the pituitary stalk.
    Wammack R; Racké K
    Neurosci Lett; 1988 Sep; 92(1):114-8. PubMed ID: 3185974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous opioid regulation of oxytocin secretion through pregnancy in the rat.
    Douglas AJ; Dye S; Leng G; Russell JA; Bicknell RJ
    J Neuroendocrinol; 1993 Jun; 5(3):307-14. PubMed ID: 8100468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibitory action by morphine on the release of oxytocin and vasopressin from the isolated neural lobe.
    Clarke G; Patrick G
    Neurosci Lett; 1983 Aug; 39(2):175-80. PubMed ID: 6633948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurohypophysial opioids and oxytocin secretion: source of inhibitory opioids.
    Bicknell RJ; Chapman C; Leng G
    Exp Brain Res; 1985; 60(1):192-6. PubMed ID: 2995108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration.
    Summy-Long JY; Rosella-Dampman LM; McLemore GL; Koehler E
    Neuroendocrinology; 1990 Apr; 51(4):376-84. PubMed ID: 1971712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphin A inhibits and naloxone increases the electrically stimulated release of oxytocin but not vasopressin from the terminals of the neural lobe.
    Bondy CA; Gainer H; Russell JT
    Endocrinology; 1988 Apr; 122(4):1321-7. PubMed ID: 2894296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid-noradrenergic interactions in the neurohypophysis. I. Differential opioid receptor regulation of oxytocin, vasopressin, and noradrenaline release.
    Zhao BG; Chapman C; Bicknell RJ
    Neuroendocrinology; 1988 Jul; 48(1):16-24. PubMed ID: 2845291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-noradrenergic interactions in the neurohypophysis. II. Does noradrenaline mediate the actions of endogenous opioids on oxytocin and vasopressin release?
    Zhao BG; Chapman C; Brown D; Bicknell RJ
    Neuroendocrinology; 1988 Jul; 48(1):25-31. PubMed ID: 2845292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone increases vasopressin secretion from the neurointermediate lobe of the hypophysis of the rat: search for the endogenous agonist.
    Knepel W; Nutto D; Meyer DK
    Life Sci; 1983; 33 Suppl 1():499-502. PubMed ID: 6664231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic opioid mechanisms controlling oxytocin neurones during parturition.
    Bicknell RJ; Leng G; Russell JA; Dyer RG; Mansfield S; Zhao BG
    Brain Res Bull; 1988 Jun; 20(6):743-9. PubMed ID: 2842005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of release of neurohypophysial hormones by endogenous opioid peptides in pregnant and parturient rats.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Brain Res; 1986 Sep; 382(2):352-9. PubMed ID: 3756522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of opioid agonists and antagonists on oxytocin and vasopressin release in vitro.
    Bicknell RJ; Chapman C; Leng G
    Neuroendocrinology; 1985 Aug; 41(2):142-8. PubMed ID: 2864649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro.
    Knepel W; Meyer DK
    J Physiol; 1983 Aug; 341():507-15. PubMed ID: 6620188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of oxytocin into blood and cerebrospinal fluid by electrical stimulation of the hypothalamus or neural lobe in the rat.
    Jones PM; Robinson IC; Harris MC
    Neuroendocrinology; 1983 Dec; 37(6):454-8. PubMed ID: 6657003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of dopamine of oxytocin release from isolated posterior lobe of the hypophysis of the rat; disinhibitory effect of beta-endorphin/enkephalin.
    Vizi ES; Volbekas V
    Neuroendocrinology; 1980 Jul; 31(1):46-52. PubMed ID: 7393404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No effect of naloxone on plasma oxytocin in normal men.
    Honer WG; Thompson C; Lightman SL; Williams TD; Checkley SA
    Psychoneuroendocrinology; 1986; 11(2):245-8. PubMed ID: 3749403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine actions of opioids.
    Pfeiffer A; Herz A
    Horm Metab Res; 1984 Aug; 16(8):386-97. PubMed ID: 6088380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The opioid receptor subtypes mu and kappa, but not delta, are involved in the control of the vasopressin and oxytocin release in the rat.
    Van de Heijning BJ; Koekkoek-Van den Herik I; Van Wimersma Greidanus TB
    Eur J Pharmacol; 1991 Dec; 209(3):199-206. PubMed ID: 1665795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.